INSIGHTS ON CLINICAL TRIAL DESIGN
-
The Psychedelic Setback: What MDMA Rejection Taught Drug Developers
Psychedelic compounds show real promise for PTSD, but proving it requires solving unblinding, bias, and safety gaps in trial design.
-
How Some Patient Organizations Are Driving Drug Development
Discover how patient-led registries are becoming a practical source of real-world evidence, drug repurposing insight, and smarter trial design.
-
A High-Touch, Patient-Centered Approach For Advancing Rare Disease Trials
On your journey to developing and executing a successful rare disease trial, it is critical to focus on patient experience and accessibility from the earliest stages of trial design.
-
CRF Validation Best Practices: Building Reliable Clinical Trial Databases
CRF validation improves data quality and efficiency. Early planning, clear edit checks, and balance reduce rework, ease site burden, and enable more reliable, streamlined study execution.
-
Participants Don't Care How Your Vendor Stack Works6/16/2026
Participants experience one study, not the vendor stack behind it. Learn how sponsors and CROs can reduce burden with support built around real study needs.
-
Stop Treating Patient Samples As Acceptable Losses7/17/2026
This short webinar excerpt pushes back on the idea that preventable biological sample loss should be tolerated as a routine part of trial execution.
-
Decentralized Trials: The Value Of Direct-To-Patient, Pharmacy-Led Solutions5/8/2026
Pharmacy-led DTP models cut site burden, improve inventory control, and expand trial access. Learn how to optimize your decentralized trial supply chain for compliance and patient outcomes.
-
Completed Clinical Trials Continued To Climb In 20246/19/2025
Data collected in this report reflects a shift toward sustained growth, reflecting rapid advancement in therapeutic areas such as oncology, autoimmune/inflammation, and central nervous system studies.
-
A Global Framework For Participant Engagement, Retention & Trial Success4/22/2026
Explore how clinical operations leaders can close the global retention gap by designing experiences that feel genuinely local, from how participants are paid to how they’re supported day to day.
CLINICAL TRIAL DESIGN SOLUTIONS
-
Discover how to seamlessly integrate a broad range of leading industry solutions to create an innovative, patient-centered approach that caters to specific diversity and clinical trial requirements.
-
By combining proactive safety measures, personalized support, and reliable logistics, the Safe-to-Site Initiative enhances the clinical trial experience by removing the challenges of participation.
-
Learn how biospecimens, clinical data, cohort identification, and specialized laboratory services come together to support complex translational and biomarker research initiatives.
-
By conducting trial visits outside of the site, physicians can expand their reach, making drug development more accessible. Read about how MRN's Home Trial Support "HTS" is the engine powering DCTs.
-
Eliminate manual friction and improve trial visibility with pre-configured, validated workflows. Standardize execution and ensure audit-ready data protection across every global site.